Armata Pharmaceuticals Stock Story
| ARMP Stock | USD 2.50 0.70 21.88% |
Slightly above 59% of Armata Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Armata Pharmaceuticals suggests that many traders are alarmed. Armata Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Armata Pharmaceuticals. The current market sentiment, together with Armata Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Armata Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Armata Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Armata daily returns and investor perception about the current price of Armata Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Armata |
Requested story not found. it has been either deleted or moved. View all stories for Armata Pharmaceuticals.
Armata Pharmaceuticals Latest Timeline
Armata Pharmaceuticals is listed for 2.50. The company reported the previous year's revenue of 4.53 M. Net Loss for the year was (69.05 M) with loss before overhead, payroll, taxes, and interest of (29.51 M).Check out Armata Pharmaceuticals Hype Analysis, Armata Pharmaceuticals Correlation and Armata Pharmaceuticals Performance. To learn how to invest in Armata Stock, please use our How to Invest in Armata Pharmaceuticals guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Armata Stock analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Armata Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Armata Pharmaceuticals. If investors know Armata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Armata Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 0.126 | Quarterly Revenue Growth 0.454 | Return On Assets (0.26) | Return On Equity (34.39) |
The market value of Armata Pharmaceuticals is measured differently than its book value, which is the value of Armata that is recorded on the company's balance sheet. Investors also form their own opinion of Armata Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Armata Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Armata Pharmaceuticals' market value can be influenced by many factors that don't directly affect Armata Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Armata Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Armata Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Armata Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.